Search

everythinglearnresearchcommunity

for

Search:↓

5α-reductase inhibitors increase the risk of sexual dysfunction, especially in men with enlarged prostate.

The document suggests that targeting the hormone DHT could be a more effective treatment for prostate cancer than targeting testosterone.

Finasteride reduces hair loss and treats BPH without major hormone changes, but may cause sexual dysfunction.

Finasteride increases hair density in female androgenetic alopecia, but individual results may vary.

Using finasteride or dutasteride may cause long-lasting erectile dysfunction.

New finasteride solution effectively reduces baldness-causing hormone, potentially with fewer side effects.

Botox increased hair count in men with baldness and might work by improving scalp blood flow.

The document concludes with guidance for doctors on diagnosing and treating hirsutism effectively and safely.

Low doses of mixed chemicals cause permanent reproductive malformations in male rats.

LGBT individuals have unique skin health needs, including higher STD risks and side effects from gender-affirming treatments, requiring dermatologists to offer knowledgeable and culturally competent care.

COVID-19 temporarily affects male reproductive health, but sperm and testosterone levels generally return to normal after three months.

Hormone imbalances can cause specific skin changes, which may help in early detection of endocrine disorders.

Hormone therapy and surgeries for transgender individuals affect their skin and hair, requiring specific dermatologic treatments and respectful care.

Syphilis has a wide range of symptoms that can look like other diseases, and if not treated, it can progress to a more serious stage, especially in HIV-positive patients.

5-alpha reductase inhibitors slightly increase the risk of sexual and mood side effects, and breast growth in men.

Androgen Deprivation Therapy for prostate cancer often reduces sexual function but intermittent therapy may be more tolerable.

ALA-PDT is effective and safe for chronic X-ray dermatitis, providing complete or partial remission.

5α reductase inhibitors treat hair loss but may cause sexual side effects and risks.

Hormone therapy affects hair growth in transgender individuals, with testosterone potentially causing hair loss in trans men and estrogen reducing facial/body hair in trans women; treatment options vary.

Psychotropic medications can cause skin reactions, including severe conditions like SJS and TEN, and it's important for psychiatrists to recognize and manage these side effects.

Testosterone therapy may slightly improve sexual function in postmenopausal women, but its long-term safety is unknown.

The article concludes that developing in vitro models for human hair structures is important for research and reducing animal testing, but there are challenges like obtaining suitable samples and the models' limitations.

Finasteride can cause one-sided breast enlargement, which disappears after stopping the drug.

Rats had lasting erectile problems after stopping a certain medication.

Testosterone therapy and surgeries like mastectomy improve transgender men's lives and mental health with low risks and high satisfaction.

Potassium channel openers show promise for treating heart disease and other conditions, but more research is needed to fully understand their effects and safety.

Testosterone therapy aims to treat hormone deficiencies and various conditions safely and effectively, but requires careful patient monitoring due to potential side effects.

The HGCA tool helps identify genes that work together by analyzing their co-expression patterns.

Consider benefits and risks of new alopecia treatments for safety.

New treatments for low male hormones improved sexual function and mood but had unclear risks, especially for older men.